bullish

Suzhou Basecare Medical IPO: First Mover with the Only NMPA-Approved PGT Product in China

355 Views27 Jan 2021 03:17
The Chinese genetic testing solutions provider for assisted reproduction, Suzhou Basecare Medical has filed for an IPO to list its shares on the Hong Kong Stock Exchange.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
chart-bar
x